IL10 and age-related macular degeneration: Administration of the small molecule, 5,15-di phenyl porphyrin (DPP), a selective inhibitor of IL-10/STAT3 signaling, has been shown to reduce pathologic neovascularization and Age-related Macular Degeneration (AMD) via inhibition of alternative activation and M2 polarization of macrophages (26).